Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Aug 8, 2013, after the close
10-Q filed Aug 9, 2013, 40 days after period end · 0001193125-13-327219
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Revenue | $26.09M | $28.50M | $27.14M |
| Net Income | -$186.00K | $774.00K | $1.37M |
| EPS Diluted | -$0.01 | $0.02 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
